TrialClinical pharmacology in drug development2026

A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Escalation Study for the Evaluation of the Safety, Tolerability, and Pharmacokinetics of Recombinant Human Plasma Gelsolin (rhu-pGSN) Following Intravenous Administration to Healthy Volunteers.

Yao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.